Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Lisette P, Yco"'
Autor:
Stephanie L. Celano, Lisette P. Yco, Matthew G. Kortus, Abigail R. Solitro, Hakan Gunaydin, Mark Scott, Edward Spooner, Ronan C. O'Hagan, Peter Fuller, Katie R. Martin, Stuart D. Shumway, Jeffrey P. MacKeigan
Publikováno v:
iScience, Vol 15, Iss , Pp 109-118 (2019)
Summary: In cancer, autophagy is upregulated to promote cell survival and tumor growth during times of nutrient stress and can confer resistance to drug treatments. Several major signaling networks control autophagy induction, including the p53 tumor
Externí odkaz:
https://doaj.org/article/1963b7c4000c4a54a648f6f246f51215
Autor:
Lisette P. Yco, Tannya R. Ibarra-Rivera, John Opoku-Ansah, André S. Bachmann, Sudhakar Ambadi, Chia-en A. Chang, Michael C. Pirrung, Christopher C. Roberts
Publikováno v:
Bachmann, André S; Opoku-Ansah, John; Ibarra-Rivera, Tannya R; Yco, Lisette P; Ambadi, Sudhakar; Roberts, Christopher C; et al.(2016). Syrbactin Structural Analog TIR-199 Blocks Proteasome Activity And Induces Tumor Cell Death.. The Journal of biological chemistry. UC Office of the President: Cancer Research Coordinating Committee (CRCC). Retrieved from: http://www.escholarship.org/uc/item/17k970vv
Multiple myeloma (MM) is an aggressive hematopoietic cancer of plasma cells. The recent emergence of three effective FDA-approved proteasome-inhibiting drugs, bortezomib (Velcade), carfilzomib (Kyprolis), and ixazomib (Ninlaro) confirms that proteaso
Autor:
Mark E. Scott, Matthew G. Kortus, Edward Spooner, Ronan C. O'Hagan, Lisette P. Yco, Peter Fuller, Katie R. Martin, Stephanie L. Celano, Jeffrey P. MacKeigan, Stuart D. Shumway, Abigail R. Solitro, Hakan Gunaydin
Publikováno v:
iScience
iScience, Vol 15, Iss, Pp 109-118 (2019)
iScience, Vol 15, Iss, Pp 109-118 (2019)
Summary In cancer, autophagy is upregulated to promote cell survival and tumor growth during times of nutrient stress and can confer resistance to drug treatments. Several major signaling networks control autophagy induction, including the p53 tumor
Autor:
André S. Bachmann, Christopher C. Roberts, Lisette P. Yco, Nicole A. Bakas, Chia-en A. Chang, Michael C. Pirrung, Chad R. Schultz
Publikováno v:
Bioorganicmedicinal chemistry. 26(2)
A family of macrodilactam natural products, the syrbactins, are known proteasome inhibitors. A small group of syrbactin analogs was prepared with a sulfur-for-carbon substitution to enhance synthetic accessibility and facilitate modulation of their s
Autor:
Heather McClung, Mark R. Burns, Ann M. Kendzicky, Giselle L. Sholler, Ping Zhao, André S. Bachmann, Katherine Samal, Eugene W. Gerner, Lisette P. Yco
Publikováno v:
International Journal of Cancer. 133:1323-1333
Neuroblastoma (NB) is associated with MYCN oncogene amplification occurring in approximately 30% of NBs and is associated with poor prognosis. MYCN is linked to a number of genes including ornithine decarboxylase (ODC), the rate-limiting enzyme in po
Publikováno v:
BMC Cancer
BMC cancer, 15(1). BioMed Central
BMC Cancer, 15. BioMed Central
Yco, L P, Geerts, D, Mocz, G, Koster, J & Bachmann, A S 2015, ' Effect of sulfasalazine on human neuroblastoma : analysis of sepiapterin reductase (SPR) as a new therapeutic target ', BMC Cancer, vol. 15, pp. 477 . https://doi.org/10.1186/s12885-015-1447-y
BMC cancer, 15(1). BioMed Central
BMC Cancer, 15. BioMed Central
Yco, L P, Geerts, D, Mocz, G, Koster, J & Bachmann, A S 2015, ' Effect of sulfasalazine on human neuroblastoma : analysis of sepiapterin reductase (SPR) as a new therapeutic target ', BMC Cancer, vol. 15, pp. 477 . https://doi.org/10.1186/s12885-015-1447-y
BACKGROUND: Neuroblastoma (NB) is an aggressive childhood malignancy in children up to 5 years of age. High-stage tumors frequently relapse even after aggressive multimodal treatment, and then show therapy resistance, typically resulting in patient d
Publikováno v:
Yco, L P, Geerts, D, Koster, J & Bachmann, A S 2013, ' PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma ', International Journal of Oncology, vol. 42, no. 4, pp. 1408-16 . https://doi.org/10.3892/ijo.2013.1836
International Journal of Oncology, 42(4), 1408-16. Spandidos Publications
International journal of oncology, 42(4), 1408-1416. Spandidos Publications
International Journal of Oncology, 42(4), 1408-16. Spandidos Publications
International journal of oncology, 42(4), 1408-1416. Spandidos Publications
Prenylated Rab acceptor 1 domain family, member 2 (PRAF2) is a novel 19-kDa protein with four transmembrane-spanning domains that belongs to the PRAF protein family. Neuroblastoma (NB) is the most common malignant extracranial solid tumor of childhoo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011e0cd15076cc9c8364a4b2ff21e918
https://research.vumc.nl/en/publications/dd19e3b9-894a-4ba3-b18e-42818b56cd1b
https://research.vumc.nl/en/publications/dd19e3b9-894a-4ba3-b18e-42818b56cd1b
Autor:
Katherine, Samal, Ping, Zhao, Ann, Kendzicky, Lisette P, Yco, Heather, McClung, Eugene, Gerner, Mark, Burns, André S, Bachmann, Giselle, Sholler
Publikováno v:
International journal of cancer. 133(6)
Neuroblastoma (NB) is associated with MYCN oncogene amplification occurring in approximately 30% of NBs and is associated with poor prognosis. MYCN is linked to a number of genes including ornithine decarboxylase (ODC), the rate-limiting enzyme in po
Autor:
Lisette P. Yco, André S. Bachmann
Publikováno v:
Cancer Research. 74:3323-3323
Receptor tyrosine kinases, such as the epidermal growth factor receptor (EGFR), mediate extracellular signaling that activates downstream cell proliferation, differentiation, and migration. Through ligand stimulation, clathrin-mediated endocytosis re
Publikováno v:
Biochemistry Insights
Biochemistry Insights, Vol 7 (2014)
Biochemistry Insights, Vol 2014, Iss 7, Pp 1-13 (2014)
Biochemistry Insights, Vol 7 (2014)
Biochemistry Insights, Vol 2014, Iss 7, Pp 1-13 (2014)
Signal transducer and activator of transcription 3 (STAT3) is an oncogenic transcription factor that has been implicated in many human cancers and has emerged as an ideal target for cancer therapy. Withaferin A (WFA) is a natural product with promisi